The clinical and laboratory approach to the CD5/CD10 negative B-cell chronic lymphoproliferative leukemias

American Journal of Hematology

Volumn 83, Issue 5, 2008, Pages 347-348

  Hanson, Curtis A ^a   Morice, William G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;

ANEMIA; ANTIGEN EXPRESSION; B CELL LEUKEMIA; B LYMPHOCYTE; CLINICAL ASSESSMENT; EDITORIAL; FLOW CYTOMETRY; GENETIC ANALYSIS; HUMAN; IMMUNOPHENOTYPING; LABORATORY DIAGNOSIS; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOPROLIFERATIVE DISEASE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RELIABILITY; SPLENOMEGALY;

ANTIGENS, CD; ANTIGENS, NEOPLASM; B-LYMPHOCYTE SUBSETS; BONE MARROW EXAMINATION; DISEASE MANAGEMENT; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MULTICENTER STUDIES AS TOPIC; NEOPLASTIC STEM CELLS; RETROSPECTIVE STUDIES;

EID: 42949106923     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21188     Document Type: Editorial

References (11)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics: Tumours of haematopoietic and lymphoid tissues. In: Kleihues P, Sobin LH, editors. World Health Organization Classification of Tumours. Lyon: IARC Press; 2001;119-187.
2. Cro L, Guffanti A, Colombi M, et al. Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias. Leukemia 2003;17:125-132.
3. Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994;8:1640-1645.
4. Ugo V, Leporrier N, Salaun V, et al. Deciphering leukemic B-cell chronic lymphoproliferative disorders. Leuk Lymphoma 2006;47:2088-2095.
5. Hanson CA, Kurtin PJ, Katzmann JA, et al. Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. Blood 1999;94:3889-3896.
6. Goldaniga M, Ferrario A, Cortelazzo S, et al. A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias. Am J Hematol 2008;83:349-354.
7. Matutes E, Oscier D, Montalban C, et al. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia 2008;22:487-495.
8. Remstein ED, Law M, Mollejo M, et al. The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma. Leukemia 2008;22:487-495.
9. Konoplev S, Medeiros LJ, Bueso-Ramos CE, et al. Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Am J Clin Pathol 2005;124:414-420.
10. Hunter ZR, Branagan AR, Manning R, et al. CD5, CD10, and CD23 expression in Waldenstrom's macroglobulinemia. Clin Lymphoma 2005;5:246-249.
11. Remstein ED, Hanson CA, Kyle RA, et al. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells. Semin Oncol 2003;30: 182-186.